Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 722 participants.
Also called NCT06044597
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 722 participants
- Sponsor
- Antonio Rapacciuolo
- Registry
-
NCT06044597
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06044597. Randomized; no masking; primary purpose treatment. Start 2023-10-01 (anticipated); primary completion 2026-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).
- Acronym
- CRUSTY +
- Condition
- Heart Failure
- Intervention (Device)
- SyncAV function on
- Lead sponsor
- Antonio Rapacciuolo
Record details
- Record id
cardio:ct-nct06044597- Content hash
9df6e19b107a6c02ce1555db0d329e153666233f63bcef207aff310f6a4eb5f7